Immunization and vaccines related implementation research advisory committee (IVIR-AC) - March 2022

7 – 11 March 2022
  • Session 1: Measles Case Fatality Ratio estimation
  • Session 2: Behavioural and social drivers of vaccination
  • Session 3: Developing a guidance on methodologies to measure the impact of vaccines in preventing antimicrobial resistance (AMR)
  • Session 4: Evaluation of a modelling approach to assess the public health value and preferred product characteristics of a Therapeutic Vaccine for Human Papilloma Virus (HPV)
  • Session 5: Evaluation of morbidity associated with enteric pathogens
  • Session 6: VIMC
  • Session 7: IA2030 

Meeting materials

Related

Background materials